Healionics

Seattle, United States

Healionics has developed a novel vascular graft, based on a platform biomaterial, offering improved vascular access for dialysis patients.

$5.5M raised

Nov 2023

Series A

Top Investors

Keiretsu CapitalKeiretsu ForumRockies Venture ClubTech Coast AngelsMid Atlantic Bio Angels

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Healionics raised?

Healionics has raised $5.5M in total funding. The most recent round was Series A. The last funding was announced in November 2023.

Who are Healionics's investors?

Healionics's investors include Keiretsu Capital, Keiretsu Forum, Rockies Venture Club, Tech Coast Angels, Mid Atlantic Bio Angels.

Where is Healionics headquartered?

Healionics is headquartered in Seattle, United States.

What does Healionics do?

Healionics has developed a novel vascular graft, based on a platform biomaterial, offering improved vascular access for dialysis patients.

What stage is Healionics at?

Healionics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 7, 2023.

MLA

"Healionics — Funding & Investors." VCBacked, November 7, 2023, https://www.vcbacked.co/company/healionics. Accessed June 17, 2026.

APA

VCBacked. (2023). Healionics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/healionics

Wikipedia (cite web)

{{cite web |title=Healionics — Funding & Investors |url=https://www.vcbacked.co/company/healionics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 7, 2023.